Abstract
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)
Title: Patent Selections:
Volume: 2 Issue: 2
Author(s): Bentham Science Publishers
Affiliation:
Abstract:
Export Options
About this article
Cite this article as:
Bentham Science Publishers , Patent Selections:, Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) 2008; 2 (2) . https://dx.doi.org/10.2174/187221408784534213
DOI https://dx.doi.org/10.2174/187221408784534213 |
Print ISSN 1872-2148 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3334 |
1
Related Articles
-
Update on the Adverse Effects of Clozapine: Focus on Myocarditis
Current Drug Safety Cannabidiol and Sodium Nitroprusside: Two Novel Neuromodulatory Pharmacological Interventions to Treat and Prevent Psychosis
CNS & Neurological Disorders - Drug Targets GPCR Heteromers and their Allosteric Receptor-Receptor Interactions
Current Medicinal Chemistry Genetic Factors in Parkinsons Disease and Potential Therapeutic Targets
Current Neuropharmacology New Insight into the Therapeutic Role of 5-HT1A Receptors in Central Nervous System Disorders
Central Nervous System Agents in Medicinal Chemistry Classical Neurotransmitters and Neuropeptides Involved in Parkinson's Disease: Focus on Anti-Parkinsonian Drugs
Current Drug Therapy GluN2B/N-methyl-D-aspartate Receptor Antagonists: Advances in Design, Synthesis, and Pharmacological Evaluation Studies
CNS & Neurological Disorders - Drug Targets Pharmacotherapy of Schizophrenia: The Past, Present and Future
Current Drug Therapy Recent Patents on Epilepsy Genetics
Recent Patents on DNA & Gene Sequences Conditioned Avoidance Response in the Development of New Antipsychotics
Current Pharmaceutical Design Applications of Lentiviral Vectors for Biology and Gene Therapy of Neurological Disorders
Current Gene Therapy <i>Withania somnifera</i> in Neurological Disorders: Ethnopharmacological Evidence, Mechanism of Action and its Progress in Delivery Systems
Current Drug Metabolism Principles and Therapeutic Relevance for Targeting Mitochondria in Aging and Neurodegenerative Diseases
Current Pharmaceutical Design Current Progresses on Nanodelivery Systems for the Treatment of Neuropsychiatric Diseases: Alzheimer’s and Schizophrenia
Current Pharmaceutical Design Quetiapine to Treat Agitation in Dementia: A Randomized, Double-Blind,Placebo-Controlled Study
Current Alzheimer Research Pharmacogenetic Studies of Psychotropic Drug-Induced Adverse Effects
Current Pharmacogenomics Atypical antipsychotics and inverse agonism at 5-HT<sub>2</sub> receptors
Current Pharmaceutical Design An Overview of Pharmacogenetics in Psychotropic Drugs
Current Psychiatry Reviews Drugs Treatment of Pain in Multiple Sclerosis
Current Clinical Pharmacology Clozapine Safety, 40 Years Later
Current Drug Safety